Photobiomodulation Therapy for Scar Quality After Facial Wound Closure
NCT: NCT07523204 · ACTIVE_NOT_RECRUITING
Brief Summary
This study is a prospective pilot randomized controlled trial designed to evaluate the effect of photobiomodulation therapy (PBMT) on scar quality following traumatic facial wound closure. Traumatic facial wounds often result in aesthetically and functionally significant scars, which may negatively affect patients' quality of life. PBMT has been proposed as a non-invasive adjunctive therapy that may enhance tissue repair, reduce inflammation, and improve scar outcomes. In this study, patients with traumatic facial wounds undergoing primary closure will be randomly assigned to receive either PBMT or sham treatment following suture removal. Scar quality will be assessed using validated clinical scales over a defined follow-up period. The findings of this study aim to provide clinical evidence regarding the effectiveness of PBMT in improving scar appearance and overall healing outcomes.
Frequently Asked Questions
What is Photobiomodulation Therapy for Scar Quality After Facial Wound Closure?
Photobiomodulation Therapy for Scar Quality After Facial Wound Closure is a clinical trial registered under NCT07523204. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07523204?
The current status of NCT07523204 (Photobiomodulation Therapy for Scar Quality After Facial Wound Closure) is: ACTIVE_NOT_RECRUITING.
When did Photobiomodulation Therapy for Scar Quality After Facial Wound Closure start?
Photobiomodulation Therapy for Scar Quality After Facial Wound Closure started on 2024-10-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.